Peter W. Nickerson
Shared Health · 290 works · 21,145 citations · h-index 67
Top works
- The Banff 97 working classification of renal allograft pathology
- SLEEP APNOEA PATIENTS HAVE MORE AUTOMOBILE ACCIDENTS
- Beneficial effects of treatment of early subclinical rejection
- National Conference to Assess Antibody-Mediated Rejection in Solid Organ Transplantation
- The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
- Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
- Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation
- Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant.
- Pre-Transplant Assessment of Donor-Reactive, HLA-Specific Antibodies in Renal Transplantation: Contraindication vs. Risk
- The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
- CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice
- Neointimal and Tubulointerstitial Infiltration by Recipient Mesenchymal Cells in Chronic Renal-Allograft Rejection
- Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry
- Flow Cytometric Crossmatching in Primary Renal Transplant Recipients with a Negative Anti-Human Globulin Enhanced Cytotoxicity Crossmatch
- Transfusion-Associated Trypanosoma cruzi Infection in a Non-Endemic Area
- IL-2 knockout recipient mice reject islet cell allografts
- Cytokines and the Th1/Th2 paradigm in transplantation
- Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts
- Computerized Image Analysis of Sirius Red–Stained Renal Allograft Biopsies as a Surrogate Marker to Predict Long-Term Allograft Function
- Class II HLA Epitope Matching—A Strategy to Minimize De Novo Donor-Specific Antibody Development and Improve Outcomes